Immunology Newswire

Immunology Newswire

Comprehensive Real-Time News Feed for Immunology.

Results 1 - 20 of 3,703 in Immunology

  1. Juno Therapeutics Soars 40% After Hours on 10-Year $1 Billion Celgene DealRead the original story

    1 hr ago | BioSpace

    Celgene And Juno Announce Ten-Year Collaboration To Advance Potentially Groundbreaking Immunotherapies For Patients With Cancer And Autoimmune Diseases a Broad strategic collaboration leveraging combined immunology expertise and assets to develop and commercialize novel immunotherapies for the treatment of cancer and autoimmune diseases a Celgene gains option to commercialize Juno programs outside North America and co-promote certain programs globally a Juno gains option to co-develop and co-promote select Celgene programs a Celgene to make initial payment of approximately $1 billion which includes the purchase of ~9.1 million shares of Juno stock at $93.00 per share, with potential to increase its stake over time a Joint conference call scheduled today at 5:00 p.m. ET, 2:00 p.m. PT SUMMIT, NJ & SEATTLE - June 29, 2015 -- Celgene Corporation and Juno Therapeutics, Inc. announced today a ... (more)

    Comment?

  2. First-Ever MERS Treatment FoundRead the original story w/Photo

    1 hr ago | Surgical Products

    ... says a lead researcher on the study, Matthew B. Frieman, PhD, an assistant professor of microbiology and immunology at the University of Maryland School of Medicine (UM SOM). "We hope that clinical study will progress on these two antibodies to see ...

    Comment?

  3. Celgene and Juno Announce Ten-Year Collaboration to Advance...Read the original story w/Photo

    3 hrs ago | Investor's Business Daily

    Broad strategic collaboration leveraging combined immunology expertise and assets to develop and commercialize novel immunotherapies for the treatment of cancer and autoimmune diseases Celgene to make initial payment of approximately $1 billion which includes the purchase of ~9.1 million shares of Juno stock at $93.00 per share, with potential to increase its stake over time SUMMIT, N.J. & SEATTLE-- -- Celgene Corporation and Juno Therapeutics, Inc. announced today a global collaboration for the development and commercialization of immunotherapies.

    Comment?

  4. Successful Vaccination Against Chlamydia InfectionsRead the original story w/Photo

    3 hrs ago | Health News Digest

    ... clusters include medical imaging, cancer research/oncology, cardiovascular medicine, medical neurosciences and immunology. In terms of content, this work falls within the subject area of the immunology cluster. Service: Science a zA mucosal vaccine ...

    Comment?

  5. First-Ever Possible Treatments For MERS; Researchers Identify Two Promising CandidatesRead the original story

    4 hrs ago | Newswise

    ... says a lead researcher on the study, Matthew B. Frieman, PhD, an assistant professor of microbiology and immunology at the University of Maryland School of Medicine (UM SOM). "We hope that clinical study will progress on these two antibodies to see ...

    Comment?

  6. UNC Lineberger Discovery Could Lead to Personalized Colon Cancer Treatment ApproachRead the original story

    6 hrs ago | Newswise

    ... author and a postdoctoral fellow at UNC Lineberger, the UNC School of Medicine Department of Microbiology and Immunology and the Department of Genetics. "We found that AIM2 inhibits tumorigenesis in multiple animal models of colorectal cancer by ...

    Comment?

  7. Celgene's Economic Castle Rests In Its Drug PipelineRead the original story w/Photo

    7 hrs ago | Seeking Alpha

    ... cancer and immune-inflammatory related diseases. Its product pipeline, which covers hematology, oncology, and immunology, is quite impressive. Celgene's main drug, Revlimid, a treatment for multiple myeloma, accounts for more than half of sales. ...

    Comment?

  8. Scientists Identify "Decoy" Molecule That Could Help Sharply Reduce Risk of Flu DeathRead the original story

    8 hrs ago | Newswise

    ... the researcher, Vladimir Y. Toshchakov, PhD, Assistant Professor in the UM SOM Department of Microbiology and Immunology. A key player in the response to flu is a group of molecules known as toll-like receptors (TLRs), which trigger the inflammatory ...

    Comment?

  9. Cell Source Appoints Dr. Steven Burakoff to Its Scientific Advisory BoardRead the original story

    11 hrs ago | Freshnews

    ... CEO of Cell Source, stated, "Dr. Burakoff's deep expertise in the fields of molecular and transplantation immunology and his experience as an advisor to global pharmaceutical companies will provide the Scientific Advisory Board with both strategic ...

    Comment?

  10. Tesaro Appoints R&D EvpRead the original story w/Photo

    16 hrs ago | Contract Pharma Breaking News

    ... roles of increasing responsibility within the R&D organization at Pfizer, where he led teams in the areas of immunology, inflammation, allergy/respiratory, and oncology. "Jeff is a great addition to the TESARO executive team," said Mary Lynne ...

    Comment?

  11. Tesaro, Inc. Appoints As Executive Vice President, Research &...Read the original story

    Yesterday | BioSpace

    ... multiple oncology programs, and a wealth of experience in building R&D organizations. Jeff's deep expertise in immunology and oncology will be invaluable to TESARO as we continue to advance our portfolio of product candidates." Dr. Hanke has more ...

    Comment?

  12. Roswell Park to partner with West African cancer centerRead the original story w/Photo

    12 hrs ago | Business Journal

    ... abroad over the last half dozen years. In May, Roswell Park announced a deal with Cuba 's Center for Molecular Immunology to develop a new lung cancer vaccine. And in 2010, the hospital began partnering with King Fahad Specialist Hospital in Dammam, ...

    Comment?

  13. New study verifies accuracy of rapid Ebola testRead the original story w/Photo

    13 hrs ago | PhysOrg Weblog

    Robert Garry, professor of microbiology and immunology at the Tulane University School of Medicine, says a study proves the new rapid Ebola test is as accurate in diagnosing the disease as the traditional test. Credit: Paula Burch-Celentano A new finger prick rapid Ebola test co-developed by Tulane University researchers is as accurate as traditional lab testing for the disease, according to an independent study published in the British medical journal The Lancet .

    Comment?

  14. Scientists identify 'decoy' molecule that could help sharply reduce risk of flu deathRead the original story

    16 hrs ago | Medical News Today

    ... the researcher, Vladimir Y. Toshchakov, Ph.D., assistant professor in the UM SOM department of microbiology and immunology. A key player in the response to flu is a group of molecules known as toll-like receptors (TLRs), which trigger the ...

    Comment?

  15. Study: ER visits for childhood food allergies up in IllinoisRead the original story w/Photo

    22 hrs ago | The Daily Gazette

    ... clean environments and are not exposed to enough bacteria. The study was published in Annals of Allergy, Asthma & Immunology and was supported by a not-for-profit group called Food Allergy Research and Education.

    Comment?

  16. 15 per cent of kids who have an anaphylactic reaction have delayed 2nd reactionRead the original story w/Photo

    Sunday Jun 21 | Neepawa Press

    ... is the largest ever to look at biphasic anaphylaxis; it is published in the journal Annals of Allergy, Asthma and Immunology. Led by researchers from the Children's Hospital of Eastern Ontario, it looked at the records of 484 children who were ...

    Comment?

  17. Just Published: "UCB, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile"Read the original story

    Yesterday | PR-inside.com

    The company develops pharmaceutical products with an emphasis on central nervous system and immunology therapeutic domains. Its products include cimzia, vimpat, keppra XR, metadate CD and tussionex pennkinetic.

    Comment?

  18. Pregnancy Outcomes in Patients with Autoimmune Diseases and Anti-Ro/SSA AntibodiesRead the original story

    Yesterday | CiteULike

    Clinical Reviews in Allergy and Immunology In Clinical Reviews in Allergy & Immunology, Vol. 40, No.

    Comment?

  19. Evidence-Based Predictors Of Biphasic Allergic Reactions In ChildrenRead the original story

    Yesterday | Scientific Blogging

    ... ergy and infectious Diseases and the Food Allergy and Anaphylaxis Network. Published in Annals of Allergy, Asthma&Immunology .

    Comment?

  20. Real-world Evaluation of Asthma Control and Treatment (REACT):...Read the original story

    Yesterday | CiteULike

    Journal of Allergy and Clinical Immunology , Vol. 119, No. 6. , pp. 1454-1461, doi:10.1016/j.jaci.2007.03.022 To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document.

    Comment?